Global Pediatric Clinical Trials Market: Key Developments
In June, 2020, Gilead Sciences initiated phase 2/3 clinical trials, to evaluate the safety, efficacy, tolerability, and pharmacokinetics of Remdesivir, an antiviral drug, in pediatric patients with coronavirus disease 2019 (COVID-19).
In November 2018, Synteract, which is a service clinical research organization (CRO) focused on the emerging biopharma segment, acquired KinderPharm, which is a clinical stage, specialty pharmaceutical company with expert resources focused exclusively on pediatric drug development. This acquisition will help Synteract, to strengthen its pediatric center of development.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients